Week 6 Flashcards

1
Q

Hypothalamus Dysfunction

A
  • The hypothalamus plays a central role in maintaining homeostasis by regulating endocrine, autonomic, behavioural, and circadian functions.
  • It is composed if discrete nuclei, each with distinct physiological responsibilities.
  • Hypothalamic dysfunction can arise from diverse structural, genetic, inflammatory, infectious, metabolic, and iatrogenic causes.
  • Damage or impairment to any of these hypothalamic nuclei disrupts specific neuroendocrine or autonomic pathways, leading to characteristic clinical syndromes.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Hypothalamus dysfunction aetiology

A

Hypothalamic nuclei can be impaired by a variety of structural and non-structural insults, including:
- Intracranial masses: e.g. craniopharyngiomas, chordoid gliomas, hypothalamic hamartomas.
- Vascular events: ischemic stroke, aneurysmal subarachnoid haemorrhage.
- Trauma or surgery: especially involving the lamina terminalis or third ventricular region.
- Medications: particularly dopamine antagonists (e.g. antipsychotics), which may disrupt dopaminergic inhibition of prolactin and GnRH.
- Inflammatory and infectious processes: such as tuberculous meningitis, neurosarcoidosis or multiple sclerosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Hypothalamus dysfunction Clinical man

A

A patient’s clinical manifestations will be diverse depending on where the dysfunction is in the hypothalamus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Hypopituitarism what is it

A

This refers to decreased secretion of pituitary hormones, which can result from either:
1) Diseases of the pituitary gland.
Or
2) Diseases of the hypothalamus = diminished secretion of hypothalamic-releasing hormones and secretion of corresponding pituitary hormones.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Hypopituitarism aetiology

A
  • Hypothalamus disorders (read info from page).
  • Pituitary disorders: impair secretion of one or more hormones commonly due to mass lesions (e.g. adenoma), infarction (e.g. from Sheehan’s Syndrome) or iatrogenic (e.g. from pituitary adenoma surgery, radiation), bleeding (e.g. due to adenoma) or infections (more likely in immunocompromised patients). These conditions commonly lead to hypopituitarism – partial or complete deficiency of anterior and/or posterior hormones.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Hypopituitarism clinical man

A
  • Depend upon the cause as well as the type and degree of hormonal insufficiency.
  • Patients may be asymptomatic or present with symptoms related to hormone deficiency or a mass lesion, or nonspecific symptoms such as fatigue.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Growth hormone deficiency Aetiology

A

Aetiology:
The causes of GH deficiency are the same as the causes of deficiencies of other pituitary hormones, for example:
- Pituitary tumour or the consequences of treatment of the tumour, including surgery and/or radiation therapy.
- Extrapituitary tumour (e.g. craniopharyngioma).
- Idiopathic.
- Sarcoidosis.
- Sheehan syndrome (excessive blood loss during or after delivery of a baby may affect the function of the pituitary gland, leading to a form of maternal hypopituitarism).
The causes of GH excess are:
- Somatotroph adenoma of anterior pituitary.
- Less common: excess secretion of GH-releasing hormone by hypothalamic tumours or neuroendocrine tumours.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

GH Deficiency clinical man

A

In children:
- Shunted growth: the most noticeable effect is reduced growth rate, leading to shorter stature compared to peers.
- Delayed puberty: children may experience delayed onset of puberty, affecting their physical development.
- Facial features: growth hormone deficiency can result in immature facial features, such as a prominent forehead and a flat nasal bridge.
In adults:
- Reduced muscle mass: adults with GH deficiency may experience a decrease in muscle mass and strength.
- Increased fat levels: there may be an increase in body fat, particularly around the abdomen.
- Metabolic disturbances: GH deficiency can lead to various metabolic issues, including changes in lipid metabolism and insulin sensitivity leading to dyslipidaemia, increased inflammatory markers, and an increased in biochemical markers of endothelial dysfunction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Hypersecretion of GH

A

Stimulation of growth of many tissues, such as skin, connective tissue, cartilage, bone, viscera, and many epithelial tissues.
In children:
- Gigantism: excess GH leads to excessive growth and height, often resulting in gigantism if it occurs before the closure of growth plates.
- Facial changes: children may develop characteristic facial features, including an enlarged jaw and forehead.
In adults:
- Acromegaly: in adults. GH excess results in acromegaly, characterised by the enlargement of bones and tissues. Particularly in the hands, feet, and face.
- Organ enlargement: there can be an increase in the size of internal organs, leading to complications like hypertension and diabetes.
- Symptoms of fatigue and general weakness.
- Common clinical comorbidities; sleep apnoea, cardiovascular dysfunction, neuropathy, hypogonadism, hyperglycaemia or a combination.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Primary Adrenal Insuffciency what is it

A

Addisons disease
a rare condition where the adrenal glands don’t produce enough cortisol and aldosterone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Primary Adrenal Insuffciency Aetiology

A
  • Autoimmune adrenalitis (most common) – autoimmune process that destroys the adrenal cortex; evidence of both humoral and cell-mediated immune mechanisms directed at adrenal cortex.
  • Infectious causes (e.g. Tuberculosis can destroy glands, HIV/AIDS (with opportunistic infections), fungal infections, bacterial sepsis  adrenal haemorrhage).
  • Infiltrative or metastatic disease (e.g. lung, breast, melanoma, lymphoma).
  • Haemorrhagic/infarction (e.g. anticoagulation, trauma, sepsis).
  • Genetic.
  • Drugs.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Primary Adrenal Insuffciency Epidemiology

A
  • Primary adrenal insufficiency is a rare condition. This affects approximately 2,500 Australians, with 100 new diagnoses made each year. In primary adrenal insufficiency, the levels of all corticosteroid hormones are affected
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Secondary adrenal insufficiency

A

Problem is in the pituitary gland (decreased ACTH). Aldosterone is preserved

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Tertiary Adrenal Insufficiency

A

The problem is in the hypothalamus (decreased CRH) or functional suppression of the hypothalamic-pituitary-adrenal (HPA) axis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Tertiary Adrenal Insufficiency Aetiology

A
  • Most common – exogenous glucocorticoids.
  • Long-term steroid therapy (oral, inhaled, topical, intra-articular).
  • Abrupt cessation of steroids without tapering.
  • Hypothalamic tumours or trauma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Clinical Man of Primary Adrenal Insufficiency

A
  • fatigue, weakness, nausea, weight loss, chronic hypotension, hypoglycaemia
  • develop slowly overtime
  • ## addisons crisis = hypoadrenal state
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Cushing syndrome what is it

A

Primarily characterised by elevated cortisol levels in the blood, which can arise from various causes, including both exogenous and endogenous factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Cushing syndrome Aetiology

A
  • Exogenous Cushing Syndrome: this occurs when cortisol is introduced from outside the body, commonly through long-term use of steroid medications. This is called Iatrogenic Cushing Syndrome and is common in high income countries where medications are often prescribed for conditions like asthma or rheumatoid arthritis due to their structural similarity to cortisol.
  • Endogenous Cushing Syndrome: this type results from the body producing excess cortisol. The most prevalent cause is a pituitary adenoma that secretes excess adrenocorticotrophic hormone (ACTH), leading to increased cortisol production from the adrenal glands. This specific condition is referred to as Cushing disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Cushing syndrome Pathogenesis

A
  • The pathogenesis of Cushing syndrome involves the dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis.
  • Normally, the hypothalamus releases corticotropin-releasing hormone (CRH), stimulating the pituitary gland to secrete ACTH, which in turn prompts the adrenal glands to produce cortisol.
  • In Cushing syndrome, this regulatory mechanism is disrupted, leading to abnormally high cortisol levels, regardless of whether the source is endogenous or exogenous
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Cushing syndrome clinical man

A

The clinical manifestations of Cushing syndrome are directly related to the effects of excess cortisol on various tissues.
- Muscle wasting: due to increased breakdown of muscle tissue.
- Skin changes: thinning of the skin, easy bruising, and abdominal striae (stretch marks).
- Bone health: increased risk of fractures due to osteoporosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Cushing syndrome and Addisons

A

C
CAUSE - autoimmmune destruction of the adrenal cortex, infections, hemorrhage, medications
HORMONE - decrease cortisol, aldosterone, androgens
CLINICAL - fatigue, weakness, weight loss, vomitting, hyperpigmentation

A
CAUSE - prolonged exposure to excess cortisol
EXO - exo steroids
ENDO- pituitary adenoma, adrenal tumor, ectopic ACTH
HORMONES - increased cortisol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Hypothyroidism what is it

A

a condition where the thyroid gland doesn’t produce enough thyroid hormones, leading to a slowdown in the body’s metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Hypothyroidism Aetiology

A
  • The overwhelming majority of patients who have hypothyroidism have thyroid disease (primary hypothyroidism). Primary hypothyroidism is due to inadequate production of thyroid hormone caused by disease of the thyroid gland.
  • Central hypothyroidism is ore rare and refers to thyroid hormone deficiency due to a disorder of the pituitary, hypothalamus, or hypothalamic-pituitary portal circulation, resulting in diminished thyroid-stimulating hormone (TSH), thyrotropin-releasing hormone (TRH) or both
24
Q

Hyperthyroidism what is it

A

The overproduction of thyroid hormones

25
Hyperthyroidism Aetiology
Several different disorders can cause hyperthyroidism: - Increased thyroid hormone synthesis: Graves’ disease (autoimmune stimulation of TSH receptor), toxic multinodular goitre. - Increased release of preformed thyroid hormone: thyroiditis, toxic adenoma. - Exogenous thyroid hormone use
26
thyroid storm
Thyroid storm, also known as thyrotoxic crisis, is a rare but severe presentation of hyperthyroidism characterised by an acute exacerbation of symptoms. It represents a life-threatening condition that requires immediate medical attention.
27
Hypoparathyroidism what is it
a condition where the parathyroid glands, which regulate calcium and phosphorus levels in the blood, don't produce enough parathyroid hormone (PTH), leading to low blood calcium (hypocalcemia)
28
Hypoparathyroidism Aetiology
- Post-surgical (most common, e.g. thyroid or parathyroid surgery). - Autoimmune destruction (as in autoimmune polyendocrine syndromes). - Genetic causes (e.g. DiGeorge syndrome). - Infiltrative diseases (e.g. hemochromatosis, Wilson’s disease).
29
Hypoparathyroidism pathophysiology
It is characterised by deficient secretion or action of parathyroid hormone (PTH): PTH normally: - Increases calcium reabsorption in kidneys. - Stimulates bone resorption to release calcium. - Increases renal conversion of vitamin D to its active form enhancing intestinal calcium absorption. In hypoparathyroidism, lack of PTH leads to: - Decreased serum calcium levels due to decreased bone resorption and reduced calcium reabsorption in kidneys. - There is also low or inappropriately normal active form of vitamin D levels, and this leads to less intestinal calcium absorption.
30
Hypoparathyroidism clinical man
Symptoms (related to hypocalcaemia): - Neuromuscular irritability, e.g. tetany, muscle cramps, carpopedal spasm, laryngospasm, facial twitching, paraesthesia’s (perioral, fingers, toes). - Psychiatric symptoms: anxiety, depression, cognitive dysfunction. - Chronic: dry skin, brittle nails, hair loss, basal ganglia calcifications, cataracts.
31
Hyperparathyroidism what is it
a condition where one or more of the parathyroid glands, small structures near the thyroid gland, produce too much parathyroid hormone (PTH)
32
Hyperparathyroidism Aetiology and pathophysiology
1. Primary hyperparathyroidism (PHPT): Autonomous overproduction of PTH, typically due to: - Parathyroid adenoma (most common, tumor). - Hyperplasia. - Rarely, parathyroid carcinoma. Increased PTH leads to: - Hypercalcaemia via increased bone resorption, increased calcium reabsorption from kidneys, and increased intestinal absorption as there is an increase conversion of Vitamin D to its active form. - Hypophosphatemia: increased renal excretion of phosphate. - Bone demineralisation over time. 2. Secondary hyperparathyroidism: Compensatory PTH elevation in response to hypocalcaemia, often due to: - Chronic kidney disease (CKD)  impaired vitamin D activation and phosphate retention. - Vitamin D deficiency or malabsorption. i.e. PTH is high, but serum calcium is low or normal.
33
Hyperparathyroidism clinical man
- Skeletal: osteopenia/osteoporosis (especially cortical bone loss). - Renal: nephrolithiasis (calcium stones), nephrocalcinosis. - Gastrointestinal: constipation, nausea, pancreatitis, peptic ulcers. - Neuromuscular: fatigue, weakness, muscle hypotonia. - Psychiatric: depression, cognitive dysfunction, anxiety. - Cardiac: shortened QT interval, arrhythmias.
34
Diabetes Mellitus what is it
a condition where there is too much sugar (glucose) in the blood - inability to produce insulin or use insulin effectively
35
Diabetes Mellitus epidemiology
- Approximately 7% of the population currently have type 2 diabetes but more common in Indigenous Australians (approx. 20%).
36
Diabetes Mellitus types
a) Type 1 diabetes: results from the body’s failure to produce insulin. b) Type 2 diabetes: results from insulin resistance, a condition in which cells fail to use insulin properly.
37
Diabetes Mellitus what happens in body
- Disorder of carbohydrate, protein, and fat metabolism. a) Results from an imbalance between insulin availability and insulin need. - Can represent: a) An absolute insulin deficiency. b) Impaired release of insulin by the pancreatic beta cells. c) Inadequate or defective insulin receptors. d) Production of inactive insulin or insulin that is destroyed before it can carry out its action. - Has a common feature of hyperglycaemia.
38
type 1 diabetes what is it
Type 1 diabetes mellitus (T1DM) is a disease involving the immune-mediated destruction of insulin-producing pancreatic B cells, leading to insulin deficiency.
39
Type 1 diabetes aetiology
1. Autoimmune Origin: T1DM is primarily caused by immune-mediated destruction of pancreatic B-cells in genetically susceptible individuals. This process begins asymptomatically and often spans months to year, with: - Genetic markers present from birth. - Immune markers (autoantibodies) appearing before hyperglycaemia. - Metabolic markers appearing as B-cell mass declines. 2. Genetic Susceptibility: - HLA genes (MCH Class II): the strongest genetic risk (e.g. HLA-DR3-DQ2 and HLA-DR4-DQ8 found in >90% of children with T1DM). - Non-HLA genes which can affect insulin expression in thymus, immune regulation, tolerance and T-cell activation. 3. Environmental Triggers: - Viruses: coxsackie B, enteroviruses, congenital rubella, SARS-CoV-2. - Diet: early exposure to cow’s milk, gluten, or cereals; low omega-3 fatty acids and vitamin D may increase risk. - Microbiome and Perinatal Factors: infant born by caesarean section, neonatal stress, jaundice. - Toxins: nitrates in water, potential links with autoimmune activation. - Immunotherapy can induce T1DM.
40
Type 1 diabetes epidemiology
- T1DM is now one of the most common chronic diseases in childhood. - no current data
41
Type 1 diabetes Pathogenesis
- T1DM is a serious chronic disease that results from a lack of endogenous insulin secretion from the pancreatic B-cells (usually due to loss of B-cells). - Although B-cell-targeted autoimmune processes and B-cell dysfunction are known to occur in T1DM, the precise pathological mechanisms are still unclear. - It is suggested that the destruction process of the pancreatic B-cells is mediated by macrophages and T lymphocytes with detectable autoantibodies to various B-cells.
42
stages of type 1 diabetes
Stage 1 – Autoimmunity Begins (Silent Phase): - Immune system starts attacking the insulin-producing B-cells in the pancreas – T lymphocytes infiltrate the islets and destroy the B-cells through the secretions of cytokines and direct cytotoxic action. - No symptoms: blood sugar is still normal. - But there are 2 specific antibodies that have developed against insulin that appear in the blood. Stage 2 – Early Glucose Changes: - More B-cells are damaged, leading to early signs of abnormal glucose levels; still no symptoms. - Laboratory signs of impaired glucose control (e.g. HbA1c: 5.7%-6.4%). Stage 3 – Clinical Diabetes: - Enough B-cell destruction causes symptomatic hyperglycaemia (high blood sugar). - Presence of hyperglycaemia indicated that autoimmune destruction of B-cells has reached the point at which insulin secretion is inadequate
43
Type 2 Diabetes what is it
a chronic condition characterized by elevated blood sugar levels due to the body's inability to use insulin properly or to produce enough of it
44
Type 2 Diabetes Aetiology
1. Genetic predisposition: - Family history increases risk: over 100 genetic loci are associated with T2DM, most affecting B-cell function and some affecting insulin action. - Certain genes may predispose individuals to develop T2DM only in obesogenic environments. 2. Lifestyle and environmental factors: - Dietary patterns: high intake of refined carbohydrates, red/processed meat, and sugar-sweetened beverages increases risk; low intake of whole grains, fibre, fruits, veg, legumes, and nuts are also lined to higher risk. The mediterranean and DASH diets are associated with a lower risk of T2DM. - Physical inactivity: sedentary behaviour reduces insulin sensitivity. Regular aerobic and resistance exercises improves insulin action and glucose metabolism. - Obesity and adiposity: central (visceral) obesity is the most significant modifiable risk factor. Excess adipose tissue leads to insulin resistance, systemic inflammation and metabolic dysregulation. 1. Genetic predisposition: - Family history increases risk: over 100 genetic loci are associated with T2DM, most affecting B-cell function and some affecting insulin action. - Certain genes may predispose individuals to develop T2DM only in obesogenic environments. 2. Lifestyle and environmental factors: - Dietary patterns: high intake of refined carbohydrates, red/processed meat, and sugar-sweetened beverages increases risk; low intake of whole grains, fibre, fruits, veg, legumes, and nuts are also lined to higher risk. The mediterranean and DASH diets are associated with a lower risk of T2DM. - Physical inactivity: sedentary behaviour reduces insulin sensitivity. Regular aerobic and resistance exercises improves insulin action and glucose metabolism. - Obesity and adiposity: central (visceral) obesity is the most significant modifiable risk factor. Excess adipose tissue leads to insulin resistance, systemic inflammation and metabolic dysregulation.
45
Type 2 Diabetes Epidemiology
- In Australia, there are over 1.2 million (4.6%) people living with Type 2 diabetes. - More common in males.
46
Type 2 Diabetes Pathophysiology
Type 2 diabetes develops due to a combination of: Insulin resistance (mainly in muscle, fat, and liver) β-cell dysfunction (impaired insulin secretion by the pancreas) Insulin Resistance Definition: Body's cells, especially in muscle and fat, respond less effectively to insulin. Causes: Mainly lifestyle-related (overeating, inactivity, obesity), but also aging and genetics. Consequences: Muscle: Reduced glucose uptake. Fat: Increased fat breakdown (lipolysis), releasing free fatty acids (FFAs), which worsen insulin resistance and harm β-cells. Liver: Insulin fails to suppress gluconeogenesis, so the liver keeps producing glucose even when it's not needed. β-cell Dysfunction Definition: Pancreatic β-cells can’t produce enough insulin to meet the body’s needs. Causes: Genetic predisposition Glucotoxicity: Chronic high blood sugar damages β-cells. Lipotoxicity: High FFAs and triglycerides harm β-cells. Amyloid deposits: Amylin (co-secreted with insulin) builds up in the pancreas and disrupts β-cell function. Inflammation: Immune cells and inflammatory molecules further damage β-cells. Progression: Initially, the pancreas compensates by producing more insulin (hyperinsulinaemia). Over time, β-cells fail due to cumulative damage and cannot maintain insulin production.
47
clinical man of type 2 diabetes
Majority of patients are asymptomatic at presentation, with hyperglycaemia noted on routine laboratory evaluation, prompting further testing - polyuria - polydipsia - blurred vision - fatigue
48
Metabolic Syndrome what is it
group of conditions that increase the risk of heart disease, stroke and T2DM. These conditions include hypertension, hyperglycaemia, visceral obesity and dyslipidaemia. Metabolic syndrome means having three or more of these conditions.The number of people with metabolic syndrome is growing including insulin resistance, impaired glucose tolerance, abdominal obesity, reduced high-density lipoprotein (HDL)-cholesterol levels, elevated triglycerides, and hypertension
49
Metabolic Syndrome diagnosis
* abdominal obesity: Waist circumference (population- and sex-specific thresholds) * elevated triglycerides: ≥150 mg/dL or on lipid-lowering therapy * reduced HDL-C: <40 mg/dL (men), <50 mg/dL (women) * elevated blood pressure: ≥130/85 mmHg or on antihypertensive therapy * hyperglycaemia: fasting plasma glucose ≥100 mg/dL or on glucose-lowering therapy
50
Metabolic Syndrome Aetiology
arises from a multifactorial interaction of genetic, environmental, and lifestyle factors. Key contributors include: Visceral and Ectopic Fat Accumulation Excess fat stored in the abdomen, liver, and muscles disrupts metabolism. Driven by both genetic predisposition and environmental influences. Adipose Tissue Dysfunction Enlarged fat cells (hypertrophy), reduced fat storage capacity, increased fat breakdown, chronic inflammation, and impaired fat formation lead to metabolic imbalance. Genetic Susceptibility Certain gene variants increase the risk of insulin resistance, visceral fat accumulation, and features like high blood sugar, abnormal lipids, and inflammation. Hormonal Differences (Sex-based) Postmenopausal women are at higher risk due to reduced oestrogen, leading to more visceral fat and liver fat. Socio-environmental Factors Urban lifestyles, poor diet, physical inactivity, and low socioeconomic status further drive the development of Metabolic Syndrome.
51
Metabolic Syndrome Pathogenesis
Visceral & Ectopic Fat Visceral fat (VAT) acts like an endocrine organ: releases FFAs, cytokines (TNF-α, IL-6), leptin, resistin Promotes insulin resistance, inhibits insulin secretion, increases liver glucose/lipid production Ectopic fat in liver, heart, muscle, pancreas → organ dysfunction Adipose Tissue Dysfunction Impaired adipogenesis → enlarged, inflamed fat cells ↑ FFAs, pro-inflammatory cytokines; ↓ adiponectin Drives insulin resistance, dyslipidaemia, inflammation Insulin Resistance (IR) Tissues become less sensitive to insulin → hyperglycaemia, hyperinsulinaemia Leads to impaired glucose metabolism, lipid accumulation, and systemic inflammation Central to MetS and cardiometabolic risk Chronic Inflammation VAT attracts immune cells → pro-inflammatory state Promotes endothelial dysfunction, insulin resistance, and thrombosis risk Vascular Dysfunction & Hypertension IR damages blood vessels → ↑ vascular resistance, endothelial dysfunction Leads to hypertension, atherosclerosis, LV hypertrophy, renal damage
52
clinical man of metabolic syndrome
* asymptomatic or subclinical in early stages * insulin resistance signs: fatigue, polyuria, polydipsia * dyslipidaemia * hypertension-related signs: headache, vision changes, end-organ damage * obesity-related conditions: obstructive sleep apnoea, osteoarthritis
53
Overweight and obesity Aetiology
- Genetics, - Neuroendocrine mechanism - diet - exercise - food - foetal over-nutrition - disorders - illness
54
Overweight and obesity Epidemiology
* Adults: 66% were overweight or obese, 34% overweight (BMI 25–29.9), 32% obese (BMI ≥30); 13% had severe obesity (BMI ≥35). Obesity prevalence increased from 19% in 1995 to 32% in 2022 * Children and Adolescents (2–17 years): 26% were overweight or obese, 8.1% were obese - higher in first nations, remoteness more too, higher in lower ses areas
55
Overweight and obesity Pathogenesis
Obesity results from dysregulated fat storage, hormonal imbalance, inflammation, and brain circuitry dysfunction, all contributing to metabolic disease Defended Fat Set-Point (Brain-Regulated) Weight loss ↓ leptin & gut hormones → ↑ hunger, ↓ energy use Body resists fat loss to maintain "set-point," even at unhealthy levels Ectopic Fat Accumulation When adipose storage is overwhelmed, fat is stored in liver, muscle, pancreas, etc. Leads to organ dysfunction, insulin resistance, and metabolic complications Adipose Tissue Expansion & Inflammation Adipocytes enlarge → outgrow blood supply → hypoxia Triggers: Apoptosis, fibrosis, ↓ capillary density Recruitment of monocytes → macrophages Release of pro-inflammatory cytokines (chronic low-grade inflammation) ↓ Adiponectin → ↓ insulin sensitivity → insulin resistance CNS Dysregulation Brain regulates appetite, satiety, and energy use Dysfunction in circuits (hypothalamus, reward pathways) → overeating, ↓ energy expenditure Emotional, memory, and control centers (e.g., amygdala, prefrontal cortex) also play roles Gut Microbiota & Inflammation Obesity alters gut bacteria → ↑ gut permeability Bacterial products (e.g., LPS) enter bloodstream → systemic inflammation Nutrient overload also triggers inflammatory pathways Inflammation contributes to tissue dysfunction & metabolic di
56
Overweight and obesity clinical man
OA obstruction of airways CVD